Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIAT
Ratios

Cullinan Therapeutics (CGEM) Accumulated Depreciation & Amortization (2020 - 2022)

Cullinan Therapeutics (CGEM) has 3 years of Accumulated Depreciation & Amortization data on record, last reported at $100000.0 in Q4 2022.

  • For Q4 2022, Accumulated Depreciation & Amortization changed 0.0% year-over-year to $100000.0; the TTM value through Dec 2022 reached $100000.0, changed 0.0%, while the annual FY2022 figure was $100000.0, 0.0% changed from the prior year.
  • Accumulated Depreciation & Amortization reached $100000.0 in Q4 2022 per CGEM's latest filing, roughly flat from $100000.0 in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $179000.0 in Q4 2020 and bottomed at $100000.0 in Q4 2021.
  • Average Accumulated Depreciation & Amortization over 3 years is $126333.3, with a median of $100000.0 recorded in 2021.
  • Peak YoY movement for Accumulated Depreciation & Amortization: plummeted 44.13% in 2021, then changed 0.0% in 2022.
  • A 3-year view of Accumulated Depreciation & Amortization shows it stood at $179000.0 in 2020, then tumbled by 44.13% to $100000.0 in 2021, then changed by 0.0% to $100000.0 in 2022.
  • Per Business Quant database, its latest 3 readings for Accumulated Depreciation & Amortization were $100000.0 in Q4 2022, $100000.0 in Q4 2021, and $179000.0 in Q4 2020.